This case report describes the first use of vemurafenib in an infant with BRAF V600E–mutated Langerhans cell histiocytosis, showing improvement in the patient’s general health and eventual complete remission.
No takes yet. Share an insight, caveat, or question.
Héritier et al. (2015) studied this question.